Eagle Asset Management Inc Neurocrine Biosciences Inc Transaction History
Eagle Asset Management Inc
- $16.7 Billion
- Q3 2024
A detailed history of Eagle Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 621,363 shares of NBIX stock, worth $70.3 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
621,363
Previous 680,034
8.63%
Holding current value
$70.3 Million
Previous $93.6 Million
23.59%
% of portfolio
0.43%
Previous 0.52%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.61 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.14 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$553 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$341 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$287 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...